AUG 19, 2026 · PHASE 1 TRIAL
A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity
ClinicalTrials.gov
This is a Phase 1 safety and pharmacokinetic study registration with no results posted; it describes planned enrollment and primary outcome measures only.
Reported
Planned enrollment128
PhasePhase 1
Primary outcome Part AAUC0-tz and Cmax of NNC6022-0001 after sing…